Nurse Practitioner in Hugo, OK Accepting Medicare
7 Nurse Practitioner nurses found. Showing 1 - 7
 Casey J Woolsey, CNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 206 N 16th St, Hugo, OK 74743 Phone: 580-920-2122 Fax: 580-920-9976 |
Lauretta White, NURSE PRACTITIONER Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1267 N 4160 Rd, Hugo, OK 74743 Phone: 405-838-2911 |
Toni Danyell Brannan, APRN, FNP-C Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 211 N 3rd St, Hugo, OK 74743 Phone: 580-326-6111 |
Mrs. Kelli Lemke, APRN-CNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 204 E. Jackson St., Hugo, OK 74743 Phone: 580-326-9555 |
Emily Dunlap, APRN Nurse Practitioner - Primary Care Medicare: Medicare Enrolled Practice Location: 1201 E Jackson St, Hugo, OK 74743 Phone: 580-326-6423 Fax: 580-326-3660 |
Kathy Bryant, APRN NP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1201 E Jackson St, Hugo, OK 74743 Phone: 580-326-6423 Fax: 580-326-3953 |
Shanete Kadan Boling, APRN, FNP-C Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 103 S 4th St, Hugo, OK 74743 Phone: 580-326-8821 |
News Archive
New drug treatment can override genetic fault that causes choroideremia
Researchers with funding from Fight for Sight have demonstrated that a new drug treatment for cystic fibrosis and Duchenne muscular dystrophy can override a genetic fault that causes choroideremia – a severe blinding disorder.
Politicians must justify for mishandling COVID-19 pandemic, argues senior editor
Politicians around the world must be held to account for mishandling the COVID-19 pandemic, argues a senior editor at The BMJ today.
Podcast: KHN's ‘What the Health?' Live from D.C.: A look ahead at health policy in 2019
The 2020 presidential campaign has begun and health is a big part of it, with Democratic candidates pledging their support for "Medicare-for-all" and many of its variations.
Pharming, Santarus reach SPA agreement with FDA for RHUCIN Phase III trial
Specialty biopharmaceutical company Santarus, Inc. and biotech company Pharming Group NV today announced that they have reached agreement with the U.S. Food and Drug Administration (FDA) on the design of a Phase III clinical study with the investigational drug RHUCIN under the Special Protocol Assessment (SPA) process that is intended to support the submission of a Biologics License Application.
Findings suggest that more help needed for family doctors to spot signs of lung cancer
The findings suggest that family doctors may not be picking up the signs of lung cancer and investigating them as appropriately as they might, or promptly enough, say the researchers.
› Verified 5 days ago
Nurse Practitioner
Registered Nurse
Physician Assistant
Licensed Practical Nurse